
<!DOCTYPE html>
<!--[if lt IE 8]>      <html class="no-js nav theme-teal lt-ie10 lt-ie9 lt-ie8  " lang="en-us"> <![endif]-->
<!--[if IE 8]>         <html class="no-js nav theme-teal lt-ie10 lt-ie9  " lang="en-us"> <![endif]-->
<!--[if IE 9]>         <html class="no-js nav theme-teal lt-ie10  " lang="en-us"> <![endif]-->
<!--[if !IE]><!-->     <html class="no-js nav theme-teal  " lang="en-us" > <!--<![endif]-->	
    <head>
        <meta charset="utf-8" />
                		<title>CDC | TB | Report of Expert Consultations on Rapid Molecular Testing... General considerations and principles for a molecular drug-resistance testing service</title>
        		
        <meta name="description" content="Centers for Disease Control and Prevention, Division of Tuberculosis Elimination" />        <meta name="keywords" content="tuberculosis, CDC, tb, t.b., t b, t.b, dtbe, USA, mycobacterium, division of tuberculosis elimination, tb control, prevention of tb, what is tb disease, for patients, for health professionals, medical authories, about tuberculosis, tb information, tb exposure, tb facts, tb testing, tests, diagnosis, screening, questions and answers" />		<meta name="viewport" content="width=device-width, initial-scale=1" />
		        <link rel="apple-touch-icon-precomposed" sizes="144x144" href="../../../../TemplatePackage/3.0/images/cdc-touch-icon-144x144.png" />
        <link rel="apple-touch-icon-precomposed" sizes="114x114" href="../../../../TemplatePackage/3.0/images/cdc-touch-icon-114x114.png" />
        <link rel="apple-touch-icon-precomposed" sizes="72x72" href="../../../../TemplatePackage/3.0/images/cdc-touch-icon-72x72.png" />
        <link rel="apple-touch-icon-precomposed" href="../../../../TemplatePackage/3.0/images/cdc-touch-icon-57x57.png" />
        <link rel="shortcut icon" href="../../../../TemplatePackage/3.0/images/favicon.ico" />	
		
		<meta name="robots" content="index,follow" />
		<meta property="cdc:template_version" content="3.0" />
		<meta property="cdc:content-id" content="413421"/>
		<meta property="cdc:revision-id" content="2"/>
				<link rel="canonical" href="http://www.cdc.gov/tb/topic/laboratory/rapidmoleculartesting/considerations.htm"/>
				<!-- Internal Release Version # 3.7 -->
                			<link rel="stylesheet" href="../../../../TemplatePackage/3.0/css/lib/bootstrap24.css" />
	<link rel="stylesheet" href="../../../../TemplatePackage/3.0/css/app.css@3.2.1.7.css" />
	<!--[if gt IE 9]><!--><!--<![endif]-->
	<!--[if IE 7]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/lib/font-awesome-ie7.css" />
	<![endif]-->
	<!--[if lt IE 9]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/ie.css" />
	<![endif]-->
	<link rel="stylesheet" media="print" href="../../../../TemplatePackage/3.0/css/print.css@3.2.1.7.css" />
	<script src="../../../../TemplatePackage/3.0/js/libs/modernizr-latest.js"></script>
	<script>
		if(!Date.now){Date.now=function now(){return new Date().getTime()}}
		var page_timing = page_timing || {};
		page_timing.page_start = Date.now();
		function $$(e){if(window.$){e()}else{setTimeout(function(){$$(e)},50)}}
		// (function(){function e(e,t){var n=e.length;while(n--){if(e[n].indexOf(t)>-1){return e[n]}}return false}var t=e(document.getElementsByTagName("html")[0].className.split(" "),"theme-");if(t){var n=document.createElement("link");n.rel="stylesheet";n.type="text/css";n.media="screen";n.href="/TemplatePackage/3.0/css/themes/"+t+".css";document.getElementsByTagName("head")[0].appendChild(n)}})();

		var settings = {}, addthis = null;
	</script>

	<meta name="application-name" content="CDC.gov"/>
	<meta property="cdc:template_version" content="3.2.1.7" />
	<meta name="msapplication-TileColor" content="#0061aa" />
	<meta name="msapplication-square70x70logo" content="/TemplatePackage/3.0/images/Win8_tile_70x70.png" />
	<meta name="msapplication-square150x150logo" content="/TemplatePackage/3.0/images/Win8_tile_150x150.png" />
	<meta name="msapplication-wide310x150logo" content="/TemplatePackage/3.0/images/Win8_tile_310x150.png" />
	<meta name="msapplication-square310x310logo" content="/TemplatePackage/3.0/images/Win8_tile_310x310.png" />
	<meta name="viewport" content="width=device-width,initial-scale=1,shrink-to-fit=no">		        




        <style type="text/css">  </style> <script type="text/javascript">(function(H){H.id=H.id.replace('no-','')})(document.documentElement)</script>        
	<link rel="stylesheet" type="text/css" href="../../../local/b/css/local.css"/>
  		    </head>
    <body>
				



				<div id="skipmenu">
	<a href="considerations.htm#searchTarget" class="skippy">Skip directly to search</a>
	<a href="considerations.htm#azTab" class="skippy">Skip directly to A to Z list</a>
	<a href="considerations.htm#nav-container" class="skippy">Skip directly to navigation</a>
	<a href="considerations.htm#share-bar" class="skippy">Skip directly to page options</a>
	<a href="considerations.htm#contentArea" class="skippy">Skip directly to site content</a>
</div>		    	<div id="wrapper">
    		
<!-- references to this removed intentionally -->
    		<header id="header">
    			<div class="container">
                    <div class="row">
                    	<div id="logo" class="span14">
                    		<!--iPad touch response and 508 voice reader issue currently under investigation -->
<a href="../../../../index.html" title="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People">
	<img src="../../../../TemplatePackage/3.0/images/masthead_subpage.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="hidden-one" />
	<img src="../../../../TemplatePackage/3.0/images/masthead_1-col.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="visible-one" />
</a>

<!-- IOS9 iPad bug work around - make sure screen readers have a readable version of the logo to read
<a class="tp-sr-only" href="https://www.cdc.gov">Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People</a>
 -->
                    	</div>
                    	<!-- search -->
                    	<div id="searchArea" class="span10 hidden-one hidden-two">							
							
<div class="hidden"><a href="considerations.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>							<div class="a2z-button pull-right hidden-one hidden-two"><a href="considerations.htm#" id="azTab">CDC A-Z Index <span class="icon-angle-down"></span></a></div>
                    	</div>
                    </div>
                    	<div class="hidden-three hidden-four" id="mobile-menu">
		<ul>
			<li id="vp1-menu-button" class="border-bottom-white"><a href="considerations.htm#" id="menu-nav"><span class="sprite-16-menu"></span>MENU</a></li>
			<li id="vp1-a2z-button" class="border-bottom-white"><a href="considerations.htm#" id="menu-az">CDC A-Z</a></li>
			<li id="vp1-search-button" class="border-bottom-white"><a href="considerations.htm#" id="menu-search"><span class="sprite-16-search-white"></span>SEARCH</a></li>
		</ul>
	</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.menu_load = Date.now(); }</script>
                    <div class="a2z-bar hide">
                    	<div>
	<ul>
		<li><a href="../../../../az/a.html">A</a></li>
		<li><a href="../../../../az/b.html">B</a></li>
		<li><a href="../../../../az/c.html">C</a></li>
		<li><a href="../../../../az/d.html">D</a></li>
		<li><a href="../../../../az/e.html">E</a></li>
		<li><a href="../../../../az/f.html">F</a></li>
		<li><a href="../../../../az/g.html">G</a></li>
		<li><a href="../../../../az/h.html">H</a></li>
		<li><a href="../../../../az/i.html">I</a></li>
		<li><a href="../../../../az/j.html">J</a></li>
		<li><a href="../../../../az/k.html">K</a></li>
		<li><a href="../../../../az/l.html">L</a></li>
		<li><a href="../../../../az/m.html">M</a></li>
		<li><a href="../../../../az/n.html">N</a></li>
		<li><a href="../../../../az/o.html">O</a></li>
		<li><a href="../../../../az/p.html">P</a></li>
		<li><a href="../../../../az/q.html">Q</a></li>
		<li><a href="../../../../az/r.html">R</a></li>
		<li><a href="../../../../az/s.html">S</a></li>
		<li><a href="../../../../az/t.html">T</a></li>
		<li><a href="../../../../az/u.html">U</a></li>
		<li><a href="../../../../az/v.html">V</a></li>
		<li><a href="../../../../az/w.html">W</a></li>
		<li><a href="../../../../az/x.html">X</a></li>
		<li><a href="../../../../az/y.html">Y</a></li>
		<li><a href="../../../../az/z.html">Z</a></li>
		<li><a href="../../../../az/0.html">#</a></li>
	</ul>
</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.a2z_load = Date.now(); }</script>                    </div>
                    <div id="searchArea-two-column" class="span24 searchbar hide hidden-three hidden-four">
						  
<div class="hidden"><a href="considerations.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>					</div>
                    <!--
	See the noscript include for modifying the emergency message. DO NOT add it here.
-->
<script>if (typeof page_timing !== 'undefined') { page_timing.emergency_load = Date.now(); }</script>
    				<div class="titlebar">
					 						<h2>


<a href="../../../default.htm">Tuberculosis (TB)</a>

</h2>
					 					</div>
    				<!-- emergency -->
<div id="emergencyContainer">
	<!--
	<div class="alert alert-error en">
		<b>Attention!</b> Uncomment this section and place the emergency message here.
	</div>
	<div class="alert alert-error esp">
		<b>&#161;Atenci&#243;n!</b> Elimine el comentario de esta secci&#243;n y colocar el mensaje de emergencia aqu&#237;.
	</div>	
	-->
</div>

<!-- no script -->
<noscript>
	<div class="alert alert-block"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../../../other/about_cdcgov.html">About CDC.gov</a>.</div>
</noscript>
<script>if (typeof page_timing !== 'undefined') { page_timing.noscript_load = Date.now(); }</script>
     			</div>
    		</header>
    		<div class="container">				
                <div id="content">
					<div class="row">
        				<!-- left nav -->
        				<div id="nav-container" class="hidden-one hidden-two span5">
    						<nav id="left" class="hidden-one hidden-two">
    							


<!-- begin left navigation items here -->
<h3><a href="../../../default.htm">Tuberculosis</a></h3>

<ul id="nav-primary">
<li><a href="../../basics/default.htm">Basic TB Facts</a> <!--3rd level nav-->
<ul class="selected" style=" display: block;">
<li><a href="../../basics/howtbspreads.htm">How TB Spreads</a></li>

<li><a href="../../basics/tbinfectiondisease.htm">Latent TB Infection and TB Disease</a></li>

<li><a href="../../basics/signsandsymptoms.htm">Signs &#38; Symptoms</a></li>

<li><a href="../../basics/risk.htm">TB Risk Factors</a></li>

<li><a href="../../basics/exposed.htm">Exposure to TB</a></li>

<li><a href="../../basics/tbprevention.htm">TB Prevention</a></li>

<li><a href="../../basics/vaccines.htm">Vaccines</a></li>

<li><a href="../../basics/tbhivcoinfection.htm">TB &#38; HIV Coinfection</a></li>

<li><a href="../../basics/glossary.htm">TB Terms</a></li>
</ul>
</li>

<li><a href="../../basics/personalstories.htm">Personal Stories</a>
<ul>
<li><a href="../../basics/deostory.htm">Deo</a></li>

<li><a href="../../basics/estebanstory.htm">Esteban and Danielle</a></li>

<li><a href="../../basics/kennistory.htm">Kenni</a></li>

<li><a href="../../basics/lilianastory.htm">Liliana</a></li>

<li><a href="../../basics/mabrukastory.htm">Mabruka</a></li>

<li><a href="../../basics/marthastory.htm">Martha</a></li>

<li><a href="../../basics/nataliestory.htm">Natalie</a></li>

<li><a href="../../basics/francenestory.htm">Rick and Francene</a></li>

<li><a href="../../basics/rosalie.htm">Rosalie and Faith</a></li>

<li><a href="../../basics/santosstory.htm">Santos</a></li>

<li><a href="../../basics/sarahstory.htm">Sarah</a></li>

<li><a href="../../basics/tristory.htm">Tri</a></li>
</ul>
</li>

<li><a href="../../testing/default.htm">Testing &#38; Diagnosis</a> <!--end 3rd level -->
<ul>
<li><a href="../../testing/whobetested.htm">Who Should be Tested</a></li>

<li><a href="../../testing/tbtesttypes.htm">Testing for TB Infection</a></li>

<li><a href="../../testing/testingbcgvaccinated.htm">Testing in BCG-Vaccinated Persons</a></li>

<li><a href="../../testing/healthcareworkers.htm">Testing Health Care Workers</a></li>

<li><a href="../../testing/testingduringpregnancy.htm">Testing During Pregnancy</a></li>

<li><a href="../../testing/diagnosingltbi.htm">Diagnosing latent TB infection and TB disease</a></li>
</ul>
</li>

<li><a href="../../treatment/default.htm">Treatment</a> <!--3rd level nav-->
<ul>
<li><a href="../../treatment/decideltbi.htm">Deciding When to Treat Latent TB Infection</a></li>

<li><a href="../../treatment/ltbi.htm">Treatment Regimens for Latent TB Infection (LTBI)</a></li>

<li><a href="../../treatment/tbdisease.htm">Treatment for TB Disease</a></li>

<li><a href="../../treatment/adverseevents.htm">Adverse Events</a></li>

<li><a href="../../treatment/tbhiv.htm">TB Treatment of Persons Living with HIV</a></li>

<li><a href="../../treatment/pregnancy.htm">TB Treatment and Pregnancy</a></li>

<li><a href="../../treatment/children.htm">TB Treatment for Children</a></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../../drtb/default.htm">Drug-Resistant TB</a></li>

<li><a href="../../research/default.htm">Research</a> <!--3rd level nav-->
<ul>
<li><a href="../../research/tbesc/default.htm">TB Epidemiologic Studies Consortium</a> <!--4th level nav-->
<ul>
<li><a href="../../research/tbesc/research_projects.htm">Research Projects</a></li>

<li><a href="../../research/tbesc/publications.htm">Publications</a></li>
</ul>
</li>

<li><a href="../../research/tbtc/default.htm">TB Trials Consortium</a> <!--4th level nav-->
<ul>
<li><a href="../../research/tbtc/projects.htm">Study Descriptions</a></li>

<li><a href="../../research/tbtc/introduction.htm">Background</a></li>
</ul>

<!--end 4th level nav--></li>

<li><a href="../../research/behavioral.htm">Behavioral &#38; Social Science Research</a></li>
</ul>
</li>

<li><a href="../../infectioncontrol/default.htm">Infection Control</a></li>

<li><a href="../../populations/default.htm">TB in Specific Populations</a> <!--3rd level nav-->
<ul>
<li><a href="../../populations/tbinafricanamericans/default.htm">African-American Community</a> <!--4th level nav-->
<ul>
<li><a href="../../populations/tbinafricanamericans/summit.htm">Stop TB in the African-American Community Summit</a></li>

<li><a href="../../populations/tbinafricanamericans/background.htm">Background</a></li>

<li><a href="../../populations/tbinafricanamericans/slideset/default.htm">Slideset</a></li>
</ul>
</li>

<li><a href="../../populations/tbinchildren/default.htm">Children</a> <!--end 4th level nav--></li>

<li><a href="../../populations/correctional/default.htm">Correctional Facilities</a></li>

<li><a href="../../populations/homelessness/default.htm">Homelessness</a></li>

<li><a href="../../populations/travelers/default.htm">International Travelers</a></li>

<li><a href="../../populations/pregnancy/default.htm">Pregnancy</a></li>

<li><a href="../../populations/healthdisparities/default.htm">Health Disparities</a> <!--                 <li><a href="/tb/topic/populations/disaster/default.htm">Disaster Responders</a>
                                                    
                                                        <ul>
                                                         <li><a href="/tb/topic/populations/disaster/default.htm">TB Guidance for Disaster Responders</a></li>
                                                         <li><a href="/tb/NewsandAnnoucements/earthquakes.htm">TB Guidance for Haiti Earthquake Responders</a></li>
                                                         <li><a href="/tb/NewsandAnnoucements/reliefworkerguidance.htm">Guidance for Relief Workers and Others Traveling to Haiti</a></li>
                                                       </ul>
                              </li>--><!--END ****--><!--end 4th level nav--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../default.htm">Laboratory Information</a> <!--3rd level nav-->
<ul>
<li><a href="../mpep/default.htm">Model Performance Evaluation Program (MPEP)</a></li>

<li><a href="../drug_testing.htm">Drug Susceptibility Testing</a></li>

<li><a href="../../../publications/guidelines/amplification_tests/default.htm">The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TB</a> <!--4th level nav-->
<ul>
<li><a href="../../../publications/guidelines/amplification_tests/background.htm">Background</a></li>

<li><a href="../../../publications/guidelines/amplification_tests/considerations.htm">General Considerations</a></li>

<li><a href="../../../publications/guidelines/amplification_tests/research.htm">Research Needs</a></li>

<li><a href="../../../publications/guidelines/amplification_tests/dst.htm">Molecular Drug Susceptibility Tests (DSTs)</a></li>

<li><a href="../../../publications/guidelines/amplification_tests/communication.htm">Communication Plan for New Recommendations</a></li>

<li><a href="generalreccommendations.htm">General Recommendations of the Expert Panel</a></li>

<li><a href="../../../publications/guidelines/amplification_tests/reccomendations_acet.htm">Recommendations to ACET, CDC, DTBE</a></li>
</ul>

<!--END *****--></li>

<li><a href="default.htm">Rapid Molecular Testing to Detect Drug-Resistant TB in the US</a> <!--4th level nav-->
<ul>
<li><a href="summary.htm">Executive Summary</a></li>

<li><a href="introduction.htm">Introduction</a></li>

<li><a href="background.htm">Background on Tests for Molecular Detection of DR</a></li>

<li><a href="considerations.htm">General Considerations and Principles for a Molecular DR Testing Service</a>�</li>

<li><a href="scenarios.htm">Possible Scenarios and Scope of Testing for a Molecular DR Testing Service</a></li>

<li><a href="researchneeds.htm">Research Needs</a></li>

<li><a href="reccommendations.htm">General Recommendations of the Expert Panel</a></li>

<li><a href="communication.htm">Communication Plan for the Report</a></li>

<li><a href="recommendations2.htm">Recommendations</a></li>

<li><a href="references.htm">References</a></li>

<li><a href="panelmembers.htm">Panel Members and CDC Participants</a></li>

<li><a href="appendix1.htm">Appendix 1</a></li>

<li><a href="appendix2.htm">Appendix 2</a></li>

<li><a href="appendix3.htm">Appendix 3</a></li>
</ul>

<!--END *****--></li>

<li><a href="../biosafetyguidance_xdrtb.htm">Interim Laboratory Biosafety Guidance for XDR <em>Mycobacterium</em> tuberculosis strains</a></li>
</ul>
</li>

<li><a href="../../../statistics/default.htm">Data &#38; Statistics</a> <!--2nd level nav-->
<ul>
<li><a href="../../../publications/factsheets/statistics/tbtrends.htm">Trends in Tuberculosis, 2015</a></li>

<li><a href="../../../statistics/tbcases.htm">TB Incidence in the United States</a></li>

<li><a href="../../../statistics/reports/2015/default.htm">Reported TB in the US, Surveillance Report</a></li>

<li><a href="../../../statistics/surv/surv2015/default.htm">Tuberculosis in the United States, 2015 (Slide Set)</a></li>

<li><a href="../../../statistics/archived.htm">Archived Surveillance Reports and Slide Sets</a></li>
</ul>
</li>

<li><a href="../../../education/professionaltools.htm">Professional Resources &#38; Tools</a> <!--2nd level nav-->
<ul>
<li><a href="../../../education/provider_edmaterials.htm">Tools for Healthcare Providers</a></li>

<li><a href="../../../education/professional-resources.htm">Resources for TB Programs</a></li>
</ul>

<!--end 2nd level nav--><!-- END EDUCATION AND TRAINING--><!-- BEGIN RESOURCES FOR TB PROGRAMS--><!--1st level nav--></li>

<li><a href="../../../publications/default.htm">Publications &#38; Products</a>
<ul>
<li><a href="../../../education/patient_edmaterials.htm">Patient and Public Materials</a></li>

<li><a href="../../../publications/factsheets/default.htm">Fact Sheets</a> <!--3rd level nav-->
<ul>
<li><a href="../../../publications/factsheets/general.htm">General</a> <!--4th level nav--></li>

<li><a href="../../../publications/factsheets/data.htm">Data &#38; Statistics</a> <!--4th level nav--> <!-- end 4th level nav--></li>

<li><a href="../../../publications/factsheets/drtb.htm">Drug-Resistant TB</a> <!--4th level nav--></li>

<li><a href="../../../publications/factsheets/prevention.htm">Infection Control &#38; Prevention</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../../../publications/factsheets/specpop.htm">TB in Specific Populations</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../../../publications/factsheets/treatment.htm">Treatment</a></li>

<li><a href="../../../publications/factsheets/testing.htm">Testing &#38; Diagnosis</a> <!--4th level nav--><!-- end 4th level--></li>

<li><a href="../../../publications/factsheets/vaccines.htm">Vaccines &#38; Immunizations</a><!--4th level nav--></li>
</ul>
</li>

<li><a href="../../../publications/guidelines/default.htm">Guidelines</a> <!--3rd level nav-->
<ul>
<li><a href="../../../publications/guidelines/contactinvestigations.htm">Contact Investigations</a></li>

<li><a href="../../../publications/guidelines/control_elim.htm">Control &#38; Elimination</a></li>

<li><a href="../../../publications/guidelines/mdr_tb.htm">Drug-Resistant TB</a></li>

<li><a href="../../../publications/guidelines/genotyping.htm">Genotyping</a></li>

<li><a href="../../../publications/guidelines/infectioncontrol.htm">Infection Control &#38; Prevention</a></li>

<li><a href="../../../publications/guidelines/laboratory.htm">Laboratory</a></li>

<li><a href="../../../publications/guidelines/hiv_aids.htm">TB &#38; HIV</a></li>

<li><a href="../../../publications/guidelines/specpop.htm">TB in Specific Populations</a><!--4th level nav-->&#160;<!--END ****--><!--end 4th level nav--></li>

<li><a href="../../../publications/guidelines/testing.htm">Testing &#38; Diagnosis</a></li>

<li><a href="../../../publications/guidelines/treatment.htm">Treatment</a></li>

<li><a href="../../../publications/guidelines/vaccines.htm">Vaccines &#38; Immunizations</a></li>

<li><a href="../../../publications/guidelines/list_date.htm">Guidelines by Date</a></li>
</ul>
</li>

<li><a href="../../../publications/guidestoolkits/default.htm">Guides &#38; Toolkits</a> <!--3rd level nav-->
<ul>
<li><a href="../../../education/corecurr/index.htm">Core Curriculum</a><!--4th level nav--></li>

<li><a href="../../../education/ssmodules/default.htm">Self-Study Modules</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../../../programs/rvct/default.htm">Report of Verified Case of Tuberculosis (RVCT)</a></li>

<li><a href="../../../publications/guidestoolkits/forge/default.htm">Forging Partnerships to Eliminate TB</a> <!--4th level nav-->
<ul>
<li><a href="../../../publications/guidestoolkits/forge/toolkitword.htm">Toolkit</a></li>
</ul>

<!--end 4th level nav--></li>

<li><a href="../../../education/cohort.htm">Understanding the TB Cohort Review Process</a></li>

<li><a href="../../../publications/ltbi/default.htm">Latent Tuberculosis Infection: A Guide for Primary Health Care Providers</a></li>

<li><a href="../../../publications/guidestoolkits/interviewing/default.htm">Effective TB Interviewing for Contact Investigation</a></li>

<li><a href="../../../education/mantoux/default.htm">Mantoux Tuberculin Skin Testing Products</a></li>

<li><a href="../../../publications/guidestoolkits/ethnographicguides/default.htm">Ethnographic Guides</a></li>

<li><a href="../../../education/skillscourse/default.htm">TB Contact Investigation Interviewing Skills Course</a></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../../../publications/newsletters/default.htm">Newsletters</a> <!--3rd level nav-->
<ul>
<li><a href="../../../publications/newsletters/notes/tbn_16/tbnotes-5.htm">TB Notes, No. 5, 2016</a></li>

<li><a href="../../../publications/newsletters/notes/tbn_16/tbnotes-4.htm">TB Notes, No. 4, 2016</a></li>

<li><a href="../../../publications/newsletters/notes/tbn_16/tbnotes-3.htm">TB Notes, No. 3, 2016</a></li>

<li><a href="../../../publications/newsletters/notes/tbn_16/tbnotes-2.htm">TB Notes, No. 2, 2016</a></li>

<li><a href="../../../publications/newsletters/notes/tbn_16/tbnotes-1.htm">TB Notes, No. 1, 2016</a>&#160;<!--<li><a href="/tb/publications/newsletters/TB_Challenge/default.htm">TB Challenge</a></li>--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../../../publications/pamphlets/default.htm">Pamphlets, Brochures, Booklets</a> <!--3rd level nav-->
<ul>
<li><a href="../../../publications/faqs/default.htm">Questions and Answers</a> <!--4th level nav--></li>

<li><a href="../../../publications/culturalmaterials.htm">Patient Education Series</a> <!--4th level nav--> <!--end 4th level nav--></li>

<li><a href="../../../publications/pamphlets/getthefacts_eng.htm">Tuberculosis - Get the Facts</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../../../publications/pamphlets/tbandhiv_eng.htm">Tuberculosis - The Connection between TB and HIV</a> <!--4th level nav--></li>

<li><a href="../../../publications/pamphlets/12-doseregimen.htm">12-Dose Regimen for Latent TB Infection-Patient Education Brochure</a> <!--end 4th level nav--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../../../publications/posters/default.htm">Posters</a> <!--3rd level nav-->
<ul>
<li><a href="../../../education/mantoux/default.htm">Mantoux Tuberculin Skin Test Wall Chart</a></li>

<li><a href="../../../worldtbday/resources.htm">World TB Day</a></li>

<li><a href="../../../publications/posters/thinktb.htm">Think TB</a></li>

<li><a href="../../../publications/posters/stoptb.htm">Stop TB</a></li>
</ul>

<!--end 4th level nav--></li>

<li><a href="../../../publications/reportsarticles/default.htm">Reports &#38; Articles</a> <!--end 3rd level nav--><!--  <ul>
                       <li><a href="/tb/publications/reportsarticles/reports.htm">Reports</a>-->
<ul>
<li><a href="../../../publications/reportsarticles/mmwr/default.htm"><em>Morbidity and Mortality Weekly Reports (MMWRs)</em></a> <!--4th level nav--></li>

<li><a href="../../../publications/reportsarticles/tbarticles.htm">DTBE Authored Journal Articles</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../../../publications/reportsarticles/labreports.htm">Tuberculosis Laboratory Aggregate Reports</a></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../../../publications/slidesets/default.htm">Slide Sets</a> <!--3rd level nav-->
<ul>
<li><a href="../../../publications/slidesets/correctionsalstaff/default.htm">The Tuberculosis (TB) in Correctional Settings</a>
<ul>
<li><a href="../../../publications/slidesets/correctionsalstaff/facilitatorguide.htm">Facilitator Guide</a></li>
</ul>
</li>

<li><a href="../../../publications/slidesets/genotyping/default.htm">Introduction to TB Genotyping</a></li>

<li><a href="../../../publications/slidesets/corecurr/default.htm">Core Curriculum</a> <!--4th level nav--><!-- end 4th level nav--></li>

<li><a href="../../../publications/slidesets/correctionalfacilities/default.htm">Epidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2014</a></li>

<li><a href="../../../publications/slidesets/corrections/default.htm">Prevention and Control of Tuberculosis in Correctional and Detention Facilities</a></li>

<li><a href="../../../publications/slidesets/infectionguidelines/default.htm">Guidelines for Preventing the Transmission of M. TB in Health care Settings</a></li>

<li><a href="../../../publications/slidesets/contactinv/default.htm">Investigation of Contacts of Persons with Infectious TB</a> <!--4th level nav--> <!--end 4th level nav--></li>

<li><a href="../../../publications/slidesets/pediatrictb/default.htm">Epidemiology of Pediatric Tuberculosis in the United States</a></li>

<li><a href="../../../publications/slidesets/ltbi/default.htm">Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection</a> <!--begin 4th level nav--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../../../publications/eresources.htm">Electronic Tools &#38; Resources</a> <!--3rd level nav--></li>

<li><a href="../../../publications/webcourseswebinars/default.htm">Web-Based Courses &#38; Webinars</a> <!--3rd level nav-->
<ul>
<li><a href="../../../webcourses/tb101/default.htm">TB 101 for Health Care Workers</a> <!--4th level nav-->
<ul>
<li><a href="../../../education/ce/tb101.htm">TB 101 CE Credits</a></li>
</ul>
</li>

<li><a href="../../../education/ce/interactive-corecurr.htm">Interactive Core Curriculum</a><!-- end 4th level nav--></li>

<li><a href="../../../programs/evaluation/default.htm">Program Evaluation</a></li>
</ul>
</li>

<li><a href="../../../publications/syndicated.htm">Content Syndication</a></li>

<li><a href="../../../publications/infographic/default.htm">Infographics</a><!--end 3rd level nav-->
<ul>
<li><a href="../../../publications/infographic/webresources.htm">Social Media Graphics</a></li>
</ul>
</li>
</ul>
</li>

<li><a href="../../../events/default.htm">Events</a></li>

<li><a href="../../../worldtbday/default.htm">World TB Day</a> <!--3rd level nav-->
<ul>
<li><a href="../../../worldtbday/resources.htm">Resources</a></li>

<li><a href="../../../worldtbday/championnomination.htm">U.S. TB Champions</a></li>

<li><a href="../../../worldtbday/2017/activities.htm">Activities</a></li>

<li><a href="../../../worldtbday/history.htm">History</a></li>
</ul>
</li>

<li><a href="../../../links/default.htm">Links</a>
<ul>
<li><a href="../../../links/tboffices.htm">State TB Control Offices</a></li>

<li><a href="../../../programs/tbwebsites.htm">TB Control Programs</a></li>
</ul>
</li>

<li><a href="../../../about/default.htm">About Us</a>
<ul>
<li><a href="../../../about/mission.htm">Mission Statement and Activities</a>
<ul>
<li><a href="../../../about/strategicplan.htm">DTBE Strategic Plan</a></li>

<li><a href="../../../programs/evaluation/indicators/default.htm">National TB Program Objectives</a></li>
</ul>
</li>

<li><a href="../../../about/orgchart.htm">Organization Chart</a></li>

<li><a href="../../../about/advisorygroups.html">Advisory Groups</a>
<ul>
<li><a href="../../../about/taskforce.htm">Federal TB Task Force</a></li>
</ul>
</li>
</ul>
</li>
</ul>


    						</nav>
    						<div class="nav-related">
							



    						


<!-- EMPTY SSI -->

							



							</div>    						    				
        				</div>
        				<div id="featureArea">
    						<div class="span19">
    							



    						</div>
        				</div>						
    					<div class="breadcrumbs hidden-one span19">
    						


<div class="bread-crumb hidden-one"></div>

    					</div>
						<div class="span19 pagetitle">	
    						    							<div class='syndicate'>
    						    						    							<div class='mSyndicate'>
    																					<h1>Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States</h1>
															    						    							</div>
    						    						    							</div>
    												</div>
						<div id="share-bar" class="span19">		
    						<div class="socialmediabar">
								<div class="row">
            						<div class="hidden-one pull-right">
        								            							            							            						</div>	
    								<div class="span8">
    									<div id="socialMediaShareContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="considerations.htm#"><span class="tp-sr-only">Recommend on Facebook</span><span id="share_facebook" class="facebookRecommend"> </span></a>
	 	<a class="share_button_twitter" title="Twitter" href="considerations.htm#"><span class="tp-sr-only">Tweet</span><span id="share_twitter" class="twitterTweet"> </span></a>
		<a class="share_button" href="considerations.htm#socialMediaShareContainer" ><img src="../../../../TemplatePackage/3.0/images/social/addthis-32.png" alt="Share" /><span class="shareButtonEn tp-sr-only" aria-label="Share">Share</span><span class="shareButtonEs tp-sr-only" aria-label="Compartir">Compartir</span></a>
	</div>
</div>

<!-- target anchor for return to top feature in VP1 -->
<a id="content-start" tabindex="-1"></a>
    								</div>
								</div>
    						</div>
    					</div>	
    					<!-- body -->
    					<div id="body" class="span19">
    						<div id="contentArea" >								
        						        																						        						                                                                                            					            						<div class='syndicate'>
            					            					            						<div class='mSyndicate'>
            					            					        							<!-- InstanceBeginEditable name="content-main" --><h3>General considerations and principles for a molecular drug-resistance testing service</h3><ol><li>13,299 TB cases were reported to CDC in 2007 (5,17). <ol type="a"><li>This includes 10,590 pulmonary and 2697 extrapulmonary cases, 10426 culture confirmed cases, 762 isoniazid-resistant cases, and 125 MDR TB cases.</li><li>Of the 10,590 pulmonary cases, 4864 were sputum smear positive for AFB, 4524 were smear negative and 7366 were sputum culture positive and 1878 were culture negative.</li></ol></li><li>Rifampin resistance is a reliable surrogate (positive predictive value &gt;95%) for MDR TB when isolated rifampin resistance is uncommon, as it is in the United States (18&#8211;20).</li><li>Molecular DR tests are useful for testing isolates and respiratory specimens directly. However, the currently available tests are highly reliable when used with AFB-smear positive specimens, but they are less reliable when used with AFB-smear negative specimens. There is little information on the performance of molecular DR tests with other types of specimens.</li><li>Both &#8216;susceptible&#8217; and &#8216;resistant&#8217; results from molecular DR tests can be useful. <ol type="a"><li>The sensitivity and specificity of molecular DR tests for rifampin are sufficiently high (&gt;97%) to use both resistant and susceptible results in case management decisions.</li><li>The sensitivity of molecular DR tests for isoniazid is not sufficient to exclude isoniazid resistance based on a negative result. However, because isoniazid resistance is about 8% in the United States, the positive predictive value for isoniazid resistance is relatively high and molecular detection of isoniazid resistance can be used in case management decisions.</li></ol></li><li>Molecular DR testing is particularly useful for <ol type="a"><li>patients suspected or at high risk of having drug-resistant TB,</li><li>very ill patients for whom drug-susceptibility information might alter case management decisions, such as patients who do not get better while taking standard first-line therapy,</li><li>outbreak or contact investigations when drug resistance is suspected in the source case or in some severely immunocompromised persons such as HIV-infected persons or those receiving dialysis in which knowledge of drug-susceptibility would be a significant benefit and affect preventive therapy decisions,</li><li>persons for whom drug-susceptibility information would influence TB Control decisions such as placing the person on a &#8216;Do Not Board&#8217;&#8224; list, and</li><li>isolates that contain a mixture of <em>M. tuberculosis</em> bacteria and other mycobacteria or respiratory specimens containing only nonviable <em>M. tuberculosis</em> bacteria.</li></ol></li><li>Molecular DR testing has significant potential added value for clinicians and TB control officials. <ol type="a"><li>Earlier detection of resistance leads to earlier initiation of an effective treatment regimen, a reduced period of infectiousness, and improved patient outcomes.</li><li>Earlier notification of drug-resistant TB cases should permit public health interventions sooner and may engage an MDR TB expert sooner in the care of the TB patient.</li><li>Earlier detection of rifampin resistance should lead to earlier testing for susceptibility to other first-line and second-line anti-TB drugs.</li></ol></li><li>Benefits of routing requests for molecular DR tests through the TB Program include <ol type="a"><li>early engagement of the TB Control Program in potential TB cases,</li><li>early engagement of TB laboratory in follow-up susceptibility testing,</li><li>improved communications between TB clinicians, controllers, and laboratorians,</li><li>reinforcement of the important role played by state and local TB Programs,</li><li>engagement of a person knowledgeable about molecular DR testing for TB early in decisions regarding whether or not to request a molecular DR test, and</li><li>avoidance of excessive and inappropriate ordering of the molecular DR tests &#8211; simply having a check-off box on a form often leads to inappropriate ordering.</li></ol></li><li>Turnaround time (TAT) must be as brief as possible to maximize benefits of molecular DR testing. The key TAT is the interval from specimen collection to time that the test result is used by the clinician for case management.</li><li>It is essential that the detection of resistance immediately trigger additional (reflex) testing for susceptibility to first and second line anti-TB drugs by conventional and molecular methods.</li></ol><p>&#8224;The CDC and the Department of Homeland Security have developed a national &#8216;Do Not Board list&#8217; to prevent commercial air travel of persons with known communicable diseases that pose a serious public health threat, such as infectious tuberculosis. A person whose name appears on a <strong>&#8220;</strong>Do Not Board<strong>&#8221;</strong> list, will not be allowed to board an airplane that is inbound to the United States, outbound from the United States, or any domestic flight inside of the United States.</p><ol start="10"><li>A potential benefit of a system for providing molecular DR tests may be expanding access to NAA testing for the initial diagnosis of TB.</li><li>State regulations need to be addressed as part of developing a regional approach. For example, laboratories, regardless of location, that conduct testing for patients in New York must be certified by New York State.</li><li>No molecular DR test has been approved by the FDA for use in the United States, although well-characterized test kits are available in Europe and elsewhere. Several validated molecular DR tests (line-probe assays, molecular beacons, and DNA sequencing) based on analyte specific reagents, often called &#8220;home-brew&#8221; or &#8220;in-house&#8221; tests are used in the United States. Each test displays similar performance characteristics. At this time, data do not demonstrate clearly the superiority of one method over another. <ol type="a"><li>Tests that detect <em>M. tuberculosis</em> DNA and drug resistance in one step have potential advantages related to lower cost, less hands-on time, simpler testing procedure, and use of a closed system. Although the currently available one-step systems have excellent performance with AFB-smear positive specimens and cultures, they perform less well when used with AFB-smear negative specimens.</li><li>A protocol that uses two methods (e.g., uses an optimized NAA assay to detect <em>M. tuberculosis</em> DNA (13&#8211;15) and a second assay to assess resistance) has potential advantages of increased sensitivity, particularly if AFB-smear negative specimens are tested, and the possibility of conducting more informative second tests (e.g., sequencing). Disadvantages may include a higher cost, more hands-on time, and potential end-product contamination.</li></ol></li><li>Specimens suitable for molecular DR testing include cultures, processed specimens (sediments), and non-processed respiratory specimens. Because of the differences in the cost of testing non-processed (processing and molecular testing) and processed specimens (only molecular testing), programs must accurately project the anticipated numbers of non-processed and processed specimens to be tested to enable the molecular DR testing laboratories to estimate the cost of the services and CDC to adequately fund the service. <ol type="a"><li>Advantages of processed specimens include (1) prior testing showed the sample was AFB+ and (2) it would not be necessary to process the specimen at the molecular DR laboratory which saves time and labor for the molecular DR testing laboratory. Potential disadvantages include possibly insufficient quantity of the remnant sample and possible errors introduced during processing may affect the molecular DR testing.</li><li>Advantages of non-processed specimens include (1) results with this specimen would be a check or confirmation of the results from conventional testing of another specimen, (2) a processing method optimized for molecular DR testing could be used, and (3) any errors in testing the first specimen would not affect the result of molecular DR testing. Potential disadvantages include (1) increased work load and cost for the molecular DR testing laboratory, (2) lengthening of the TAT at the molecular DR testing laboratory, (3) delays for obtaining a second specimen, and (4) sometimes a follow-up specimen may be AFB-negative due to sporadic shedding of TB bacilli.</li><li>Advantages of testing cultures using molecular DR test include increased sensitivity and accuracy of the molecular DR test. Potential disadvantages include the time needed to obtain an isolate and the expense of shipping viable cultures may be as much as 5-fold more than for specimens.</li></ol></li><li>Molecular DR tests enhance but do not replace culture or conventional drug-susceptibility testing. <ol type="a"><li>Molecular DR tests are not as sensitive as culture for detecting <em>M. tuberculosis</em> complex bacteria.</li><li>Molecular DR tests are not as sensitive as culture-based proportion tests for detecting resistant bacteria in a mixture of resistant and susceptible bacteria.</li><li>Molecular DR tests are most useful for rifampin, somewhat less useful for isoniazid, and not currently available for other anti-TB drugs although some are being developed.</li><li>False-positive and false-negative molecular DR test results do occur.</li></ol></li><li>In the case of discrepancies between conventional and molecular DR test results for rifampin and isoniazid, clinicians should use the conventional DS results and clinical judgment for case management decisions until the discrepancy is resolved.</li><li>Failure of molecular DR tests can be caused by the presence of inhibitors in the sample that prevent or reduce NAA. Inhibitors appear to be present in 2% to 5% of respiratory specimens tested by NAA (21). Procedures must be in place to ensure that inhibition does not cause falsely negative or non-interpretable molecular DR test results. This may include internal controls to detect inhibitors and reflex repeat testing of samples suspected to contain inhibitors with steps taken to reduce inhibition (e.g., dilution or purification of DNA).</li><li>Shipping costs will be substantial. In the Florida molecular DR testing program, the contract cost of FedEx next-day shipments for specimens is $11 to $28 ($3 to $5 for shipping container plus $8 [weekday] or $23 [Saturday] for transport). The cost of U.S. Postal Service next day shipments of specimens is $16.75 plus the cost of the container. For isolates, the cost of FedEx is $97 to $115 ($12 to $15 for the container plus $85 [weekday] or $100 [Saturday] for transport). The cost of shipping isolates to the genotyping laboratories using the CDC FedEx account is $27 per shipment plus the cost of the container.</li><li>Reagent costs for the currently validated molecular DR tests range from $8 to $30 per sample. It is estimated that one technician can perform 20 molecular DR tests per day. Additional operating costs include time and materials needed for processing samples; preparing samples for molecular DR testing; entering, verifying and reporting results; technical assistance and consultation; proficiency testing; quality laboratory management; equipment; information technology, and overhead.</li><li>Cost efficiency, rapid turnaround time, and expertise would be enhanced by establishing high-volume regional laboratories offering molecular DR tests.</li><li>New funds will be needed to cover the costs of the molecular DR testing program. Potential sources of non-CDC funds to partially offset the cost of the program include the Robert Wood Johnson Foundation, Centers for Medicare and Medicaid Services, and insurance providers.</li><li>Good communication between laboratorians, clinicians, and public health officials will be critical to optimizing the benefits of molecular DR testing. Standard language or statements to include in laboratory reports of molecular DR test results are needed, such as the information in points 4a, 4b, and 16 above, to assist clinicians interpret the results.</li><li>Education of laboratorians, clinicians, TB controllers, and policy makers on the appropriate use and interpretation of molecular DR tests for TB will be essential.</li></ol><!-- InstanceEndEditable --><!-- /end .main-inner --><div id="linkPolicy"><!-- --></div><!-- /end #content-main-->             					            					            						</div>
            					            					            						</div>
            													        						                                                                                        						                                                                								<!-- Related Nav Area -->
								<div class="nav-related hidden-three hidden-four">
									



									


<!-- EMPTY SSI -->

								</div>
    							<!-- Persistent Content Area -->
    							<div id="content-secondary">
                                    



            						


<!-- EMPTY SSI -->

    							</div><!-- /end #content-secondary -->
    						</div><!-- /end #contentArea -->
    					</div><!-- /end body -->	
					</div>
					<div class="row">
						<div class="span24 visible-one">
																											</div>
					</div>
					<div class="row">
						<div class="span24">
                            <div id="plugin-legend" class="pluginOff">
	<h5>File Formats Help:</h5><span><a href="../../../../Other/plugins/index.html">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</a></span>
	<ul>
		<li class="plugin-pdf"><a href="../../../../Other/plugins/index.html#pdf"><span class="sprite-16-pdf">Adobe PDF file</span></a></li>
		<li class="plugin-ppt"><a href="../../../../Other/plugins/index.html#ppt"><span class="sprite-16-ppt">Microsoft PowerPoint file</span></a></li>
		<li class="plugin-word"><a href="../../../../Other/plugins/index.html#doc"><span class="sprite-16-word">Microsoft Word file</span></a></li>
		<li class="plugin-excel"><a href="../../../../Other/plugins/index.html#xls"><span class="sprite-16-excel">Microsoft Excel file</span></a></li>
		<li class="plugin-wmv"><a href="../../../../Other/plugins/index.html#wmv"><span class="sprite-16-wmv">Audio/Video file</span></a></li>
		<li class="plugin-qt"><a href="../../../../Other/plugins/index.html#qt"><span class="sprite-16-qt">Apple Quicktime file</span></a></li>
		<li class="plugin-real"><a href="../../../../Other/plugins/index.html#ram"><span class="sprite-16-rp">RealPlayer file</span></a></li>
		<li class="plugin-text"><a href="../../../../Other/plugins/index.html#text"><span class="sprite-16-txt">Text file</span></a></li>
		<li class="plugin-zip"><a href="../../../../Other/plugins/index.html#zip"><span class="sprite-16-zip">Zip Archive file</span></a></li>
		<li class="plugin-sas"><a href="../../../../Other/plugins/index.html#sas"><span class="sprite-16-sas">SAS file</span></a></li>
		<li class="plugin-epub"><a href="../../../../Other/plugins/index.html#epub"><span class="sprite-16-ebook">ePub file</span></a></li>
		<li class="plugin-ris"><a href="../../../../Other/plugins/index.html#ris"><span class="sprite-16-ris">RIS file</span></a></li>
	</ul>
</div>
						</div>
					</div>
					<!-- date stamp -->
					<div id="datestamp" class="row" itemscope="itemscope" itemtype="http://schema.org/WebPage">
						<div class="span24">
    						<ul> 
            					            						<li class="last-reviewed">Page last reviewed: <span itemprop="lastReviewed">September 1, 2012</span></li>
            													            					            						<li class="last-updated">Page last updated: <span itemprop="dateModified">September 1, 2012</span></li>
            					        							<li class="content-source">Content source:
    									



 <ul class="noindent">
  <li class="" itemprop="sourceOrganization" itemscope="itemscope" itemtype="http://schema.org/Organization"> <a href="../../../../tb.1.html" itemprop="url">Division of Tuberculosis Elimination</a></li>
 </ul>


        							</li>
									



    						</ul>
						</div>
					</div>					
				</div><!-- /end #content -->
			</div><!-- /.container for content -->					
			<!-- footer -->
				<footer id="footer" class="cdcSlimFooter">
	
 <!-- include eng footerSubSocialMedia.html -->
<div class="socialMedia">
	<div class="container">
		<nav class="followcdc">
			<ul>
				<li><a href="../../../../Other/emailupdates.1.html"><span class="sprite-24-govd"></span><span class="tp-sr-only">Email</span></a></li>
				<li><a href="https://www.facebook.com/CDC" target="_blank"><span class="sprite-24-facebook"></span><span class="tp-sr-only">Recommend</span></a></li>
				<li><a href="https://twitter.com/CDCgov" target="_blank"><span class="sprite-24-twitter"></span><span class="tp-sr-only">Tweet</span></a></li>
				<li><a href="https://www.youtube.com/user/CDCstreamingHealth" target="_blank"><span class="sprite-24-youtube"></span><span class="tp-sr-only">YouTube</span></a></li>
				<li><a href="https://www.instagram.com/CDCgov/" target="_blank"><span class="sprite-24-instagram"></span><span class="tp-sr-only">Instagram</span></a></li>
			</ul>
		</nav>
		<nav class="cdcmedia">
			<ul>
				<li><a href="https://www2c.cdc.gov/podcasts"><span class="sprite-24-listen"></span><span class="tp-sr-only">Listen</span></a></li>
				<li><a href="../../../../cdctv.1.html"><span class="sprite-24-watch"></span><span class="tp-sr-only">Watch</span></a></li>
				<li><a href="https://www2c.cdc.gov/podcasts/rss.asp"><span class="sprite-24-rss"></span><span class="tp-sr-only">RSS</span></a></li>
			</ul>
		</nav>
	</div>
</div>
 <!-- /include eng footerSubSocialMedia.html -->

	<div class="container">
		<div class="cdcLinks">
			<div class="container">
				<ul>
					
<!-- include eng footerSubCdcLinks.html-->
<li>
	<nav>
		<h6 class="hidden-four hidden-three">ABOUT <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../../../about/default.htm">About CDC</a></li>
			<li><a href="https://jobs.cdc.gov">Jobs</a></li>
			<li><a href="../../../../funding.1.html">Funding</a></li>
		</ul>
	</nav>
</li>
<li>
	<nav>
		<h6 class="hidden-four hidden-three">LEGAL <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../../../Other/policies.html">Policies</a></li>
			<li><a href="../../../../Other/privacy.html">Privacy</a></li>
			<li><a href="../../../../od/foia.1.html">FOIA</a></li>
			<li><a href="../../../../eeo/nofearact/index.htm">No Fear Act</a></li>
			<li><a href="https://oig.hhs.gov" class="no-link">OIG</a></li>
		</ul>
	</nav>
</li>
<!--/ include eng footerSubCdcLinks.html-->

				</ul>
			</div>
		</div>
		<div class="cdcContact">
			<div class="container">
				<ul>
					<li class="local-contact">
						
 <!-- include eng footerSubGlobalContact1.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="address" itemscope="itemscope" itemtype="https://schema.org/PostalAddress">
			<span itemprop="streetAddress">1600 Clifton Road</span>
			<span itemprop="addressLocality">Atlanta</span>,
			<span itemprop="addressRegion">GA</span>
			<span itemprop="postalCode">30329-4027</span>
			<span itemprop="addressCountry">USA</span>
		</span><br />
		<span class="value" itemprop="telephone">800-CDC-INFO (800-232-4636)</span>,
		<span class="value" itemprop="telephone">TTY: 888-232-6348</span><br />
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx" class=" default no-link">Email CDC-INFO</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact1.html -->

					</li>
					<li class="contact">
						
 <!-- include eng footerSubGlobalContact2.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.hhs.gov" class="no-link">U.S. Department of Health & Human Services</a></span>
		</span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
        	<span itemprop="url"><a href="https://www.hhs.gov/open" class="no-link">HHS/Open</a></span>
        </span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.usa.gov/" class="no-link">USA.gov</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact2.html -->

					</li>
				</ul>
			</div>
		</div>
	</div>
</footer>			<!-- /#footer -->
			<div id="totop" class="off visible-one">Top</div>
        </div>
		<script>page_timing.libs_start = Date.now();</script><script src="../../../../TemplatePackage/3.0/js/libs.min.js@3.2.1.7"></script><script>page_timing.libs_end = Date.now();page_timing.core_start = Date.now();</script><script src="../../../../TemplatePackage/3.0/js/core.min.js@3.2.1.7"></script><script>page_timing.core_end = Date.now();</script><!-- Start Site Settings Overrides -->
<script>
CDC.Constants.set("flexSliderVideoDomains", ['youtube.com','ytimg.com','vimeocdn.com'], 'es');
	CDC.Global.settings.includeCDCInBreadCrumbBar=true;
	CDC.Global.settings.includePageInBreadCrumbBar=true;
	CDC.Global.settings.catchJSErrors=true;
	CDC.Global.settings.enableExternalLinks=true;
	CDC.Global.settings.enableFileIcons=true;
	CDC.Global.settings.simulateMobile=true;
</script>
<!-- End Site Settings Overrides --><script>page_timing.app_start = Date.now();</script><script src="../../../../TemplatePackage/3.0/js/app.min.js@3.2.1.7"></script><script>page_timing.app_end = Date.now();</script>		
		        			<!-- Begin Survey scripts -->
<script src="../../../../JScript/foresee/foresee-trigger.js"></script>
<script src="../../../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->
			
            <script>if (typeof page_timing !== 'undefined') { page_timing.metrics_start = Date.now(); }</script>
<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->

<!-- SiteCatalyst code version: H.21. -->
<script src="../../../../JScript/metrics/topic_levels.js"></script>
<script src="../../../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script>

	enquire.register(CDC.Global.selectors.vp1, function() {
		s.prop49 = 1;
	});
	enquire.register(CDC.Global.selectors.vp2, function() {
		s.prop49 = 2;
	});
	enquire.register(CDC.Global.selectors.vp3, function() {
		s.prop49 = 3;
	});
	enquire.register(CDC.Global.selectors.vp4, function() {
		s.prop49 = 4;
	});

            
            


    s.pageName=document.title;
    s.channel="NCHSTP/DTBE";
    
    siteCatalyst.setLevel1("NCHHSTP"); 
    siteCatalyst.setLevel2("DTBE");
    
    

            
                        
            s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();



if(s_code) {
	document.write(s_code);
}



if (document.location.protocol) {


	var cookieManagment = {
		getUuid : function (strPrefix) {
			strPrefix = strPrefix || "";
			var d = new Date();
			var seconds = Math.round(d.getTime() / 1000);
			return strPrefix + Math.floor((1 + Math.random()) * 0x10000).toString(16).substring(1) + "-" + seconds.toString();
		},
		setCookie : function (cname, cvalue, exdays, domain) {
			domain = domain || ".cdc.gov";
			var d = new Date();
			d.setTime(d.getTime() + (exdays*24*60*60*1000));
			var expires = "expires="+ d.toUTCString();
			document.cookie = cname + "=" + cvalue + ";" + expires + ";domain=" + domain + ";path=/";
		},
		getCookie : function (cname) {
			var name = cname + "=";
			var ca = document.cookie.split(';');
			var i = ca.length;
			while (i --) {
				var c = ca[i];
				while (c.charAt(0)==' ') {
					c = c.substring(1);
				}
				if (c.indexOf(name) == 0) {
					return c.substring(name.length,c.length);
				}
			}
			return "";
		},
		init : function () {



			var currCookieVal = cookieManagment.getCookie('cdc_s_vi');

			if (!currCookieVal.length || currCookieVal.indexOf('[CS]v1') != -1) {
				var newCookieVal = cookieManagment.getUuid('[CS]v2') + "-" + cookieManagment.getUuid('');
				cookieManagment.setCookie("cdc_s_vi", newCookieVal, 7);
				return newCookieVal;
			}
			return currCookieVal;
		}
	};


	var cdcSessionID = cookieManagment.init();

	s3 = s_gi("cdcgovvistorid");

	var sKey, override = {
		fun: "cdcgovvistorid",
		trackingServer: "cdc.112.2o7.net"
	};

	s3.visitorID = cdcSessionID;

	for (sKey in s) {
		if (s.hasOwnProperty(sKey)) {
			if (override.hasOwnProperty(sKey)) {
				s3[sKey] = override[sKey];

			} else {

			}
		}
	}
	updateVariables(s3);


	var s_code_uvid = s3.t();
	if(s_code_uvid) {
		document.write(s_code_uvid);
	}
}




</script>
<script type="text/javascript">
if(navigator.appVersion.indexOf('MSIE')>=0) { document.write(unescape('%3C')+'\!-'+'-'); }
</script>
<noscript><a href="http://www.omniture.com"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<script>if (typeof page_timing !== 'undefined') { page_timing.metrics_end = Date.now(); }</script>
				


<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
});
</script>
<!--<![endif]-->

    	



						    </body>
	</html>
